In this work, we improved on BrcaDx (https://apalania.shinyapps.io/brcadx/) for cancer vs control screening and examined a cluster of adjoining learning problems in breast cancer heterogeneity: (i) identification of metastatic cancers; (ii) molecular subtyping (TNBC, HER2, or luminal); and (iii) histological subtyping (invasive ductal or invasive lobular). Here, ERBB2 is linked to breast carcinoma.